Selecta Biosciences, Inc.
SELB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $39 | $0 | $111 | $85 |
| % Growth | – | -100% | 30.2% | – |
| Cost of Goods Sold | $0 | $0 | $72 | $69 |
| Gross Profit | $0 | $0 | $38 | $16 |
| % Margin | 0% | – | 34.7% | 19.2% |
| R&D Expenses | $45 | $72 | $72 | $69 |
| G&A Expenses | $30 | $41 | $24 | $21 |
| SG&A Expenses | $30 | $41 | $24 | $21 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $8 | $0 | $0 | $0 |
| Operating Expenses | $83 | $112 | $96 | $90 |
| Operating Income | $0 | -$86 | $15 | -$5 |
| % Margin | 0% | – | 13.1% | -5.4% |
| Other Income/Exp. Net | $0 | -$152 | $20 | -$5 |
| Pre-Tax Income | -$77 | -$239 | $35 | -$10 |
| Tax Expense | -$0 | -$19 | -$1 | $16 |
| Net Income | -$77 | -$220 | $35 | -$26 |
| % Margin | -199% | – | 31.9% | -30.2% |
| EPS | -0.5 | -1.42 | 0.24 | -0.22 |
| % Growth | 64.8% | -691.7% | 209.1% | – |
| EPS Diluted | -0.5 | -1.42 | 0.24 | -0.22 |
| Weighted Avg Shares Out | 155 | 155 | 145 | 114 |
| Weighted Avg Shares Out Dil | 155 | 155 | 146 | 114 |
| Supplemental Information | – | – | – | – |
| Interest Income | $7 | $0 | $1 | $3 |
| Interest Expense | $0 | -$3 | $3 | $3 |
| Depreciation & Amortization | $0 | $1 | $2 | $0 |
| EBITDA | $0 | -$241 | $16 | -$7 |
| % Margin | 0% | – | 14.6% | -8.1% |